
-
Pakistan retaliates against India in spiralling conflict
-
S. Korea conservative party begins process to switch presidential candidate
-
Fijian Drua grieve death of Castres winger Raisuqe
-
Pakistan says Indian missiles strike air bases as conflict spirals
-
Spieth seeks career Slam as rivals ponder Rory Slam chances
-
Major difference for McIlroy at PGA after winning Masters
-
Top-ranked Korda shares LPGA Americas lead in repeat bid
-
US and China prepare for trade talks as Trump floats tariff cut
-
US projected to hit debt limit in August: Treasury chief
-
'You're gonna be the Pope,' Leo XIV's brother recalls telling him
-
Guardiola says Man City season has been toughest in management
-
'It's terrific': Chicago hails hometown hero Pope Leo XIV
-
Europe leaders head to Kyiv on unprecedented visit
-
Pakistan warns won't de-escalate as conflict with India spirals
-
Stocks mixed as global markets eye US-China tariff talks
-
Serbia's Vucic seeks low-price gas in Putin meeting
-
German Holocaust survivor and witness-bearer Margot Friedlaender dies at 103
-
Timberwolves launch probe after fan's 'racially charged' abuse
-
Giro over for Landa after high-speed opening stage crash
-
US approves first at-home cervical cancer screening device
-
FIFA Women's World Cup expanded to 48 teams from 2031
-
Mitchell leads, Lowry charges and Rory five back at rainy Truist
-
Gauff holds nerve to join Sabalenka in Italian Open third round
-
Israel not involved in Gaza food distribution under US aid plan: envoy
-
Margot Friedlaender, Germany's voice of Holocaust remembrance
-
Fallen giant Hamburg close in on top-flight redemption
-
Dozens of minors killed in Mexico cartel infighting
-
Trump fires librarian of US Congress
-
Spurs will show no fear against Man Utd in Europa League final: Van de Ven
-
Renowned Holocaust survivor Margot Friedlaender dies at 103
-
Woods, 16-year-old Charlie, misses out in US Open qualifier
-
Pakistan says India has put neighbours 'closer to major conflict'
-
On patrol for jihadists with Mauritania's camel cavalry
-
France, Poland sign treaty with mutual defence pledge
-
NATO chief seeks defence spending at 5% of GDP by 2032: Dutch PM
-
La Rochelle head coach O'Gara suspended for five weeks
-
Measles roars back in the US, topping 1,000 cases
-
Fulham boss Silva refuses to rule out Saudi switch
-
From Chicago to Chiclayo: Peruvian town hails adoptive son and pope
-
Ivorian women fight FGM with reconstructive surgery
-
Pedersen wins opening stage of Giro d'Italia in Albania
-
Stocks mixed despite hopes for US-China tariff talks
-
US, Swiss agree to speed up tariff talks
-
Trump floats cutting China tariffs to 80% ahead of trade talks
-
Pedersen wins opening stage of Giro d'Italia
-
Marc Marquez sets Le Mans lap record in French MotoGP practice
-
Jungle music: Chimp drumming reveals building blocks of human rhythm
-
Guardiola tells Man City stars to question their hunger after troubled season
-
Putin, Xi, Steven Seagal and missiles: Russia's Red Square parade
-
Trump suggests lower 80% China tariff ahead of Geneva trade talks

Indonesia approves first homegrown Covid-19 vaccine
Indonesia has approved its first locally developed Covid-19 vaccine for emergency use, the head of the country's public health agency said Friday, hailing it as a step toward "the nation's independence in access to medicine".
Jakarta has stressed the importance of developing national vaccines since the beginning of the pandemicbut it currently relies on China's Sinovac and the Western-made Moderna and Pfizer-BioNTech mRNA jabs.
The IndoVac jab, developed by state-owned pharmaceutical company Bio Farma and Texas-based Baylor College of Medicine, can now be used as a primary dose for an unvaccinated or partially vaccinated adult in the world's fourth most-populous country.
"The development... of a domestic vaccine is a pride for us Indonesians as a foundation and as the first step to achieve the nation's independence in access to medicine," head of the national food and drugs agency (BPOM) Penny Lukito said at a press conference Friday.
The medical chief said IndoVac had shown an efficacy rate of 92 percent, while there were no reports of death linked to it in trials and reported side effects were "generally mild".
A clinical study to use it as a booster jab is underway, Lukito said.
The agency also announced it had granted emergency use approval for an mRNA vaccine developed in China, becoming the first country to do so.
The inoculation developed by Walvax Biotechnology will be locally produced in Indonesia, the BPOM chief said.
The homegrown IndoVac jab has been granted a halal certificate, meaning it can be administered in line with the Islamic faith in Muslim-majority Indonesia.
Indonesia became the epicentre of Asia's Covid-19 pandemic in July last year as the Delta variant swept through the country.
Daily cases declined significantly by the end of the year but the spread of Omicron brought confirmed cases back to 30,000 a day.
It has since seen another sharp fall in case numbers andeliminated quarantine requirements for vaccinated travellers.
In total,Southeast Asia's largest economy has reported over 6.4 million confirmed cases with nearly 160,000 deaths.
Vaccination rollout has also been relatively slow compared to developed nations, with less than two-thirds of the population of 270 million receiving two jabs.
Y.Aukaiv--AMWN